Open AccessHyperbaric oxygen therapy affects insulin sensitivity/resistance by increasing adiponectin, resistin, and plasminogen activator inhibitor-I in rats
Author(s) -
Cemil Kahraman,
Hüseyin Yaman
Publication year - 2021
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-2011-76
Subject(s) - resistin , insulin resistance , medicine , adiponectin , endocrinology , quantitative insulin sensitivity check index , plasminogen activator inhibitor 1 , plasminogen activator , triglyceride , insulin , homeostasis , cholesterol , insulin sensitivity
Hyperbaric oxygen therapy (HBOT) causes insulin sensitivity, but the reason for this is not known yet. The aim of the present study was to investigate the effect of HBOT on insulin sensitivity via resistin, plasminogen activator inhibitor-I (PAI-I), and adiponectin.